Name | alpha-Methyldopa sesquihydrate |
Synonyms | DISCONTINUED alpha-Methyldopa sesquihydrate (-)-3-(3,4-Dihydroxyphenyl)-2-Methyl-L-alanine sesquihydrate |
CAS | 41372-08-1 |
EINECS | 609-918-1 |
Molecular Formula | C10H13NO4·1·5H2O |
Molar Mass | 238.24 |
Melting Point | >300 °C(lit.) |
Water Solubility | 0.1-1 g/100 mL at 23 ºC |
Appearance | Shape neat, color White to Off-White |
Storage Condition | 2-8°C |
Stability | Stable, but may be light sensitive. Very hygroscopic. Undergoes catalytic oxygenation in the presence of magnesium, cupric, cobalt, nickel and ferric ions. Store under a dry atmosphere. |
Physical and Chemical Properties | Bioactive Methyldopa hydrate (L-(-)-α-Methyldopa hydrate) is an α-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopa hydrate is a prodrug that is metabolized in the central nervous system (α-Methyllepinephrine). |
Use | Use L-Methyldopa is a beta-blocker cardiovascular drug that has a good effect on moderate-procedure primary and renal hypertension. |
Risk Codes | R20/21 - Harmful by inhalation and in contact with skin. R36/37/38 - Irritating to eyes, respiratory system and skin. R42/43 - May cause sensitization by inhalation and skin contact. R65 - Harmful: May cause lung damage if swallowed |
Safety Description | 24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
RTECS | YP2860000 |
FLUKA BRAND F CODES | 10-23 |
HS Code | 2922504500 |
Wu Fan macro , tiny flowers , Yang Xueyan , shuhaiying , Zhou Weiguo
Abstract:
(3 ',4'-dimethoxyphenyl)-2-amino-2-methylpropionitrile was obtained from 3, 4-dimethoxyphenylacetone by Strecker reaction, L-(3 ',4'-dimethoxyphenyl)-2-amino-2-methylpropionitrile hydrochloride is then resolved with L-tartaric acid and hydrolyzed, demethylation gave the target product L-methyldopa in 50.4% yield.
Key words:
L-methyldopa 3, 4-dimethoxyphenylacetone Strecker reaction
DOI:
10.3969/j.issn.1001-9677.2008.02.015
cited:
year:
2008
invention patent
Application (patent) number:
CN201711461044.4
application date:
20171228
Public/Announcement Number:
CN108147974A
Public/announcement date:
20180612
applicant (patent):
Shandong Xinhua Pharmaceutical Co., Ltd.
inventor:
Wang Bing , Shen Ping , Yan Pei , Wang Yiyun , hole Blue , fan Chunwei , Wang Xichun , Wang Zhi
National and provincial code:
CN370303
Abstract:
The invention relates to a preparation process of L-methyl methanone, belonging to the field of organic chemical synthesis. The preparation process of L methyl methyl methyl ester comprises the following steps: 1. L methyl DOPA and methanol were added sequentially, and hydrogen chloride gas was introduced; 2. The esterification reaction took place at 045 °c for 1072 hours; 3. After completion of the esterification reaction, the product was obtained by filtration, dissolution, neutralization, crystallization, centrifugation and drying. The preparation process of the invention can improve the yield and reduce the energy consumption, and at the same time, the mother liquor can be recycled, the cost is reduced, and the environment is friendly.
Abstract:
Objective to confirm the structure of L-methyldopa. Methods ultraviolet, infrared, hydrogen spectrum, carbon spectrum and mass spectrum were used to analyze the structure. Results The maximum absorption peak was red-shifted in 0.1mol · L-1 sodium hydroxide solution. The infrared spectrum showed that the molecule contained hydroxyl, Amino, carbonyl and benzene ring; the molecular ion peak m/z of the mass spectrum was 211. Conclusion The structure of L-methyldopa can be confirmed by the above method.Key words:
L-methyldopa Structure corroboration
DOI:
CNKI:SUN:XDYD.0.2009-S1-015
year:
2009